{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:19:26Z","timestamp":1788056366735,"version":"build-2784847793"},"reference-count":73,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NCI R01-CA253615, NCI R01-CA253615-02S1"],"award-info":[{"award-number":["NCI R01-CA253615, NCI R01-CA253615-02S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","award":["Shaughnessy Family Fund for Nano-ImmunoEngineering"],"award-info":[{"award-number":["Shaughnessy Family Fund for Nano-ImmunoEngineering"]}],"id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/2162402x.2025.2583553","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:57:35Z","timestamp":1765522655000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Virus nanoparticle intratumoral vaccines for HER2\n                    <sup>+<\/sup>\n                    malignancies"],"prefix":"10.1080","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1601-9369","authenticated-orcid":false,"given":"Miguel A.","family":"Moreno-Gonzalez","sequence":"first","affiliation":[{"name":"Aiiso Yufeng Li Family Department of Chemical and NanoEngineering, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Shu and K.C. Chien and Peter Farrell Collaboratory, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Center for Nano-ImmunoEngineering, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Moores Cancer Center, University of California, University of California, San Diego (UCSD)","place":["La Jolla, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5474-2355","authenticated-orcid":false,"given":"Jessica Fernanda Affonso","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Aiiso Yufeng Li Family Department of Chemical and NanoEngineering, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Shu and K.C. Chien and Peter Farrell Collaboratory, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Center for Nano-ImmunoEngineering, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Moores Cancer Center, University of California, University of California, San Diego (UCSD)","place":["La Jolla, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8788-2816","authenticated-orcid":false,"given":"Manuel L.","family":"Penichet","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA)","place":["Los Angeles, United States"]},{"name":"Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles (UCLA)","place":["Los Angeles, United States"]},{"name":"The Molecular Biology Institute, University of California, Los Angeles (UCLA)","place":["Los Angeles, United States"]},{"name":"The California NanoSystems Institute (CNSI) at University of California, Los Angeles (UCLA)","place":["Los Angeles, United States"]},{"name":"UCLA AIDS Institute","place":["Los Angeles, United States"]},{"name":"UCLA Jonsson Comprehensive Cancer Center","place":["Los Angeles, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0130-0481","authenticated-orcid":false,"given":"Nicole F.","family":"Steinmetz","sequence":"additional","affiliation":[{"name":"Aiiso Yufeng Li Family Department of Chemical and NanoEngineering, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Shu and K.C. Chien and Peter Farrell Collaboratory, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Center for Nano-ImmunoEngineering, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Moores Cancer Center, University of California, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Department of Bioengineering, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Department of Radiology, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Institute for Materials Discovery and Design, University of California, San Diego (UCSD)","place":["La Jolla, United States"]},{"name":"Center for Engineering in Cancer, Institute of Engineering in Medicine, University of California, San Diego (UCSD)","place":["La Jolla, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2470152"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00924-9"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/852748"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00579-0"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101947"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020779"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2867"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11751"},{"key":"e_1_3_6_10_1","unstructured":"Greenwich LifeSciencesInc. A Randomized Multicenter Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of HER2\/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2\/Neu Positive Subjects with Residual Disease or High-Risk PCR After Both Neoadjuvant and Postoperative Adjuvant Trastuzumab-Based Therapy (FLAMINGO-01); Clinical trial registration NCT05232916; clinicaltrials.gov 2025. (accessed 2025-02-24). https:\/\/clinicaltrials.gov\/study\/NCT05232916."},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw150"},{"key":"e_1_3_6_12_1","unstructured":"Academic and Community Cancer Research United Phase II Trial to Evaluate Immune-Related Biomarkers for Pathological Response in Stage II-III HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy With Subsequent Randomization to Multi-Epitope HER2 Vaccine vs. Placebo in Patients With Residual Disease Post-Neoadjuvant Chemotherapy; Clinical trial registration NCT04197687; clinicaltrials.gov 2023. (accessed 2025-02-24). https:\/\/clinicaltrials.gov\/study\/NCT04197687."},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3997"},{"issue":"10","key":"e_1_3_6_14_1","first-page":"3361","article-title":"Antitumor effect of new HER2 peptide vaccination based on b cell epitope","volume":"31","author":"Miyako H","year":"2011","unstructured":"Miyako H, Kametani Y, Katano I, Ito R, Tsuda B, Furukawa A, Saito Y, Ishikawa D, Ogino K, Sasaki S, et al. Antitumor effect of new HER2 peptide vaccination based on b cell epitope. Anticancer Res. 2011;31(10):3361\u20133368.","journal-title":"Anticancer Res"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(04)00083-2"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01392"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1994.tb02079.x"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1998.tb03298.x"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.105"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.46.3.280"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0327-z"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0655"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.162"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1408749"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c06600"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14145"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636658"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0293-11.2011"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06126-w"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6030037"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.5b04877"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.201900003"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000940"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1039\/d0bm01219j"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0425"},{"key":"e_1_3_6_36_1","unstructured":"Davar DNeoadjuvant Phase II Study of TLR9 Agonist CMP-001 in Combination With Nivolumab in Stage IIIB\/C\/D Melanoma Patients With Clinically Apparent Lymph Node Disease; Clinical trial registration NCT03618641; clinicaltrials.gov 2025. (accessed 2025-03-05). https:\/\/clinicaltrials.gov\/study\/NCT03618641."},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9516-5_10"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202100014"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2004.04.011"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.1c00443"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.1c13183"},{"issue":"2","key":"e_1_3_6_42_1","first-page":"179","article-title":"In vivo properties of three human HER2\/neu-expressing murine cell lines in immunocompetent mice","volume":"49","author":"Penichet ML","year":"1999","unstructured":"Penichet ML, Challita PM, Shin SU, Sampogna SL, Rosenblatt JD, Morrison SL. In vivo properties of three human HER2\/neu-expressing murine cell lines in immunocompetent mice. Lab Anim Sci. 1999;49(2):179\u2013188.","journal-title":"Lab Anim Sci"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b01523"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545797"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002107"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2015.292"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c05090"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.06.010"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.8.4175"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2206"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-014-0029-x"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-380121"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.117101"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.1.20"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1001"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri954"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.11.003"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.05.003"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00566-3"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.12.2103"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.12.5321"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2023.03.007"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.12.030"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.201800139"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122909"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669474"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.01.041"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau6085"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-020-0183-x"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26568"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004841"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.12.125"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1154-7"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2017.1298749"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2025.2583553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:11:26Z","timestamp":1766095886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2025.2583553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/2162402X.2025.2583553"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2025.2583553","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2583553"}}